Analysis updated on Oct. 14, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Our AI ranks Cbdmd, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Cbdmd, Inc. is a small-cap company with a market capitalization of $4M. It ranks number 16 by market capitalization among the 16 Perfumes, Cosmetics & Other Toilet Preparations issuers in our coverage with a current forecast.
A per-ticker accuracy statistic for YCBD is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.5%, sell < -0.6%, strong sell < -1.7% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-14 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, YCBD included.
Follow YCBD free90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Perfumes, Cosmetics & Other Toilet Preparations peers listed below that report each metric.
| Metric | YCBD | Rank |
|---|---|---|
| Market Cap | $4M | 16/16 |
| P/B Ratio | 0.48x | 11/13 |
| Book Value/Share | $0.73 | – |
| Revenue/Share | $1.87 | – |
| FCF/Share | $-0.22 | – |
| Metric | YCBD | Rank |
|---|---|---|
| ROE | -35.2% | 12/13 |
| ROA | -22.0% | 12/16 |
| ROIC | -28.8% | 12/12 |
| Gross Margin | 57.7% | 8/14 |
| Operating Margin | -13.9% | 12/15 |
| Net Margin | -13.8% | 11/15 |
| EBT Margin | -13.8% | 12/15 |
| Metric | YCBD | Rank |
|---|---|---|
| Current Ratio | 2.50x | 7/16 |
| Quick Ratio | 1.37x | 7/16 |
| D/E Ratio | 0.60x | 9/14 |
| Financial Leverage | 1.60x | 11/14 |
| Interest Coverage | -345.2x | 13/13 |
| Working Capital | $5M | 11/16 |
| Metric | YCBD | Rank |
|---|---|---|
| Operating Cash Flow | -$2M | 13/17 |
| Free Cash Flow | -$2M | 11/11 |
| Capital Spending | -$190K | 4/11 |
| FCF/Sales | -11.5% | 10/11 |
| CapEx/Sales | 0.9% | 8/11 |
| Metric | YCBD | Rank |
|---|---|---|
| Asset Turnover | 1.59x | 3/14 |
| Receivables Turnover | 22.6x | 4/12 |
| Inventory Turnover | 2.6x | 8/13 |
| Fixed Assets Turnover | 62.5x | 3/13 |
| Days Sales Outstanding | 16 days | 9/12 |
| Days Inventory | 143 days | 5/13 |
| Payables Period | 61 days | 7/12 |
| Cash Conversion Cycle | 97 days | 5/11 |
| Metric | YCBD | Rank |
|---|---|---|
| Total Revenue | $20M | 10/14 |
| Operating Income | -$2M | 11/16 |
| Net Income | -$2M | 11/16 |
| Cost of Goods Sold | $9M | 10/15 |
| Metric | YCBD | Rank |
|---|---|---|
| Shares Outstanding | 11M | – |
| Total Current Assets | $8M | 58.6% of assets |
| Cash & Short-term Investments | $2M | 16.1% of assets |
| Accounts Receivable | $930K | 7.1% of assets |
| Inventory | $3M | 26.4% of assets |
| Total Liabilities | $5M | 37.5% of assets |
| Short-term Debt | $2M | 12.1% of assets |
Companies classified under the same SEC industry code as Cbdmd, Inc. (Perfumes, Cosmetics & Other Toilet Preparations): 19 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| YCBD Cbdmd, Inc. | ▲ | $4M |
| CL Colgate Palmolive Co | ▼ | $71.71B |
| EL Estee Lauder Companies Inc | ▼ | $36.08B |
| KVUE Kenvue Inc. | ▶ | $34.11B |
| ELF E.L.F. Beauty, Inc. | ▼ | $6.38B |
| IPAR Interparfums Inc | ▼ | $3.65B |
| COTY Coty Inc. | ▲ | $2.60B |
| EPC Edgewell Personal Care Co | ▼ | $1.31B |
| WALD Waldencast Plc | ▲ | $97M |
| SLSN Solesence, Inc. | ▲ | $70M |
| SHFH Scientist Home Future Health Ltd | ▼ | $40M |
| AXIL Axil Brands, Inc. | ▶ | $40M |
| UG United Guardian Inc | ▲ | $32M |
| DQWS Dswiss Inc | ▶ | $17M |
| CABR Caring Brands, Inc. | ▲ | $14M |
| BNKK Bonk, Inc. | ▶ | $10M |
| HLN Haleon Plc | ▼ | N/A |
| KARX Karbon-X Corp. | ▼ | N/A |
| ODD Oddity Tech Ltd | ▶ | N/A |
Charlotte, North Carolina--(Newsfile Corp. - April 10, 2025) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA) (the "Company" or "cbdMD") one of the nation's leading and most highly trusted ...
Good afternoon. Welcome to cbdMD's, Inc. June 30, 2024 Third Fiscal 2024 Quarter and Earnings Call and Update. This afternoon, the company issued a press release that provided an overview of its third ...
Results from the canine clinical study suggest that cbdMD's proprietary blend promotes mobility in dogs Charlotte, North Carolina--(Newsfile Corp. - April 18, 2023) - cbdMD®, Inc. (NYSE American: YCBD ...
Our AI ranks Cbdmd, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
A per-ticker accuracy statistic for YCBD is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Cbdmd, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
19 issuers in our coverage, YCBD included, share the SEC industry code Perfumes, Cosmetics & Other Toilet Preparations. The largest are: Colgate Palmolive Co (CL), Estee Lauder Companies Inc (EL), Kenvue Inc. (KVUE), E.L.F. Beauty, Inc. (ELF), Interparfums Inc (IPAR), Coty Inc. (COTY).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.